Navigation Links
InNexus Biotechnology Announces New EGFR Antibody DXL1218 Targeting Colorectal Cancer and Announces $1.25 Million Private Placement
Date:11/7/2008

- Innovative Biotech Targets Another Large Well-Known Product and Continues

Expansion of Antibody Therapeutics Pipeline -

BRITISH COLUMBIA, Canada, Nov. 7 /PRNewswire-FirstCall/ -- InNexus Biotechnology Inc., (OTC Bulletin Board: IXSBF; TSX Venture: IXS; http://www.ixsbio.com), a drug development company commercializing the next generation of monoclonal antibodies based on its Dynamic Cross Linking (DXL(TM)) technology, announces the development of a new antibody product from its DXL(TM) platform technology, DXL1218 (EGFR), for the prospective treatment of colorectal cancer.

"Recent experimental data suggests that DXL1218 (EGFR) is superior to competing commercialized products on the market, such as ERBITUX(R) (cetuximab), in terms of potency and efficacy," said Jeff Morhet, CEO and Chairman of InNexus. "I am very excited, as this latest development lends further support to the robustness and predictability of the DXL(TM) platform and the superiority of products from the platform over presently commercialized offerings."

Speaking on InNexus' announcement, Pablo Legorreta, Chief Executive Officer of Royalty Pharma said, "We are quite pleased with the rapid progress of our research partner InNexus. Jeff has had a vision for rapid product development based on DXL(TM) technology coupled with advanced in vivo studies and a significant regulatory strategy. We look forward to their continued rollout of products and performance."

Private Placement

InNexus also announces it intends to issue 10% unsecured convertible debentures, for maximum proceeds to InNexus of $1.25 million. Each debenture will be convertible into common shares of InNexus at the rate of one common share for each $0.10 of debt converted. The debenture will have a term of 2 years and net proceeds from the private placement will be used by InNexus for research and development and general corporate business
'/>"/>

SOURCE InNexus Biotechnology Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. InNexus Biotechnology Receives Patent Grants in Europe
2. InNexus Biotechnology CEO to Present at the 7th Annual BIO Investor Forum
3. InNexus Biotechnology CEO to Present at BioContactQuebec 2008
4. St. Josephs Hospital and InNexus Biotechnology Enter Collaborative Partnership
5. InNexus Biotechnology Strengthens Patent Team With New Leadership
6. InNexus Biotechnology CEO to Present at The Wall Street Analyst Forum in NYC
7. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
8. InNexus Biotechnology CEO and Chief Scientific Officer to Present at IBCs Annual World Congress Conference in Boston on Aug 6th
9. TechConnect World 2009 Matches Tomorrows Technology Solutions with Todays Business Needs for Clean-Technology, Biotechnology and Nanotechnology
10. Lixte Biotechnology Holdings Announces New Appointment to Board of Directors
11. Bolder BioTechnology Receives $1.6 million NIH Grant to Continue Development of Multiple Sclerosis Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... Inc. (NYSE: IMA ), a global leader in ... through the merger of rapid diagnostics and health management, has ... B Convertible Perpetual Preferred Stock ( IMA-PB). The dividend will ... amount per share equal to the quotient of (a) $3.00 ...
(Date:12/2/2009)... Spectrum Blue Steel is emerging as one of the fastest ... of True Green Energy Group and True Green Planet,s President ... recycling business for over 25 years, stated that Spectrum Blue ... the stage for spectacular earnings because of the bi products ...
(Date:12/2/2009)... Dec. 2 Nearly 600 medical research executives, scientists, ... development approaches and innovative funding strategies at the inaugural ... FasterCures, the Washington-based center of the Milken Institute, ... collaborations needed to turn a scientific discovery into an ...
(Date:12/2/2009)... 2 , - ... , Coinciding with the ... Republic is hosting an international conference in Libreville,(Gabon) ... Africa. The,conference will be attended by government and ...
Breaking Biology Technology:Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Libreville International Conference 2-3 June 2010 2
... N.J., May 28 National Stem Cell,Holding, Inc. (OTC: ... steps to,change its name to Proteonomix, Inc. The change ... Michael Cohen, President/CEO, stated: "Our new name reflects the ... development stage and,commencing the commercialization of our technologies. These ...
... Global Corporate Finance, Management and ... Manufacturing Experience -, ... announced today the appointment of Gordon H.,Busenbark to the company,s ... officer of Xytis Pharmaceuticals, a privately,held development-stage specialty pharmaceuticals company ...
... Shimon Slavin of the,International Center for Cell ... Aviv,Sourasky Medical Center, and Professor Dimitrios Karussis, ... Kerem, are the,recipients of the "International Adult ... by the Worldwide Center for Adult Stem ...
Other Biology Technology:National Stem Cell Holding, Inc. Announces the Change of Its Name to Proteonomix, Inc. 2National Stem Cell Holding, Inc. Announces the Change of Its Name to Proteonomix, Inc. 3Nventa Appoints Gordon H. Busenbark to Board of Directors 2Israeli Scientists Recipients of 2008 International Adult Stem Cell Award 2
(Date:12/4/2009)... of statewide data taken from 1998-2001, women in Oregon ... than three times likely to report they were discriminated ... during pregnancy and delivery. , In addition, reporting ... among mothers with Medicaid coverage, and four times more ...
(Date:12/4/2009)... of heart cells, University of Iowa investigators have shown ... (CaM kinase), disrupts the electrical activity of heart cells. ... University, was published online Dec. 3 in the journal ... have developed great interest in calmodulin kinase II as ...
(Date:12/3/2009)... plant and animal species can be likened to emptying a ... potential medicines into the trash, or replacing every local cuisine ... their habitats may not just make the world boring. New ... risk for catching some nasty disease. , "Habitat destruction and ...
Breaking Biology News(10 mins):Lower income women report more insurance-based discrimination during pregnancy, delivery 2U-Iowa study helps advance heart-related research 2Species down, disease up 2Species down, disease up 3Species down, disease up 4Rehab Specialist K C Clark Joins Alliance Seating 26 Mobility in Washington 55032 1Rehab Specialist K C Clark Joins Alliance Seating 26 Mobility in Washington 55032 2Daylight could help control our weight 55027 1Daylight could help control our weight 55027 2Typeamom net on Smart Goals for Weight Loss 55025 1
... February 25, 2008 -- Researchers at the Harvard School ... type of optical tweezer with the potential to make ... as microfluidic chips. The tweezer, consisting of a Fresnel ... ability to trap particles without the need for high ...
... by eco-tourists, divers and aquarium keepers alike, may be at ... the Chevroned Butterflyfish is a stark example of how human ... with blind alleys from which they may be unable to ... Excellence for Coral Reef Studies Media Release and James Cook ...
... nearly 1 million people taking cholesterol-lowering statins often experience ... case when a diabetic takes medication for intestinal worms, ... for the purported health effects of green tea? ... explanation for these and other physiological mysteries. The answers, ...
Other Biology News:Engineers demonstrate a new type of optical tweezer 2Butterfly fish 'may face extinction' 2Butterfly fish 'may face extinction' 3New chemical tool kit manipulates mitochondria, reveals insights into drug toxicity 2New chemical tool kit manipulates mitochondria, reveals insights into drug toxicity 3
... assay based on measurenment of enzyme activity ... coated microtiter plate. The procedure includes two ... controls, 2nd enzyme reaction) separated by ... for the determination of human enzymaticaly active ...
... Incubator/Shaker HT is designed for ... Incubator/Shaker HT is ideal for ... and primer extension assays. The ... as a one-cabinet model, allowing ...
... Source: Pseudomonas atlantica Description: Beta-Agarase is ... fragments from low-melting-temperature agarose. Beta-Agarase digests ... Tested User Friendly Properties: Heat Inactivation: ... Da Optimum pH: 6.5 Purity: Tested ...
iEMS Thermal Microplate Holder...
Biology Products: